Research
Hormonal
Bariatric surgery and endoscopy increase satiation by restricting gastric size and enhance postprandial incretin levels.
Surgical options can be effective for enhancing satiation and managing obesity through hormonal mechanisms.
StrongSupportsmedium confidence
Bariatric surgery and endoscopy increase satiation by restricting gastric size; in addition Roux‐en‐Y gastric bypass and to a lesser extent sleeve gastrectomy...increase postprandial circulating incretins, reducing appetite.
Why this rating
The abstract summarizes findings from a review, indicating a comprehensive analysis.
Source
Incretin impact on gastric function in obesity: physiology, and pharmacological, surgical and endoscopic treatments
Michael Camilleri · The Journal of Physiology · 2024
DOI 10.1113/jp287535
reviewCited 6×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →